mRNA Vaccines
DBCAT005631Pharmacologic class
Vaccines formulated with recombinant mRNAs which are taken up by the host cells that translate the mRNA and present the translated proteins to the immune system as antigens in a manner similar to that which... A DrugBank category of 15 drugs. 12 of them are approved.
What you can answer from here — as of January 13, 2022
Which targets do mRNA Vaccines share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account